Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 for Chronic Skin Inflammation
NCT06387212Completed
- Sponsor
- Nakhia Impex LLC
- Start
- Apr 2024
- Primary completion
- May 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in dermatitis, sponsored by Nakhia Impex LLC. Primary endpoints: Skin dryness scale at 960 minutes, Fair or smooth skin scale at 960 minutes and 3 more. Started Apr 2024; status: completed.
02
Drugs
ha35
03
Conditions
dermatitis
Beyond the preview
Go deeper on NCT06387212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387212.